Transfar Zhilian Past Earnings Performance
Past criteria checks 0/6
Transfar Zhilian's earnings have been declining at an average annual rate of -13.7%, while the Chemicals industry saw earnings growing at 6.3% annually. Revenues have been growing at an average rate of 13.5% per year. Transfar Zhilian's return on equity is 3.4%, and it has net margins of 1.7%.
Key information
-13.7%
Earnings growth rate
-10.8%
EPS growth rate
| Chemicals Industry Growth | 12.1% |
| Revenue growth rate | 13.5% |
| Return on equity | 3.4% |
| Net Margin | 1.7% |
| Next Earnings Update | 29 Oct 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Transfar Zhilian makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 29,707 | 497 | 1,912 | 429 |
| 31 Mar 24 | 31,813 | 585 | 1,925 | 412 |
| 31 Dec 23 | 33,637 | 591 | 1,841 | 395 |
| 30 Sep 23 | 34,500 | 641 | 1,801 | 409 |
| 30 Jun 23 | 35,412 | 676 | 1,770 | 393 |
| 31 Mar 23 | 36,894 | 765 | 1,740 | 380 |
| 31 Dec 22 | 36,998 | 745 | 1,817 | 381 |
| 30 Sep 22 | 38,405 | 1,921 | 1,815 | 428 |
| 30 Jun 22 | 37,957 | 2,156 | 1,791 | 427 |
| 31 Mar 22 | 36,740 | 2,266 | 1,812 | 431 |
| 31 Dec 21 | 35,512 | 2,249 | 1,788 | 429 |
| 30 Sep 21 | 32,454 | 1,793 | 1,913 | 388 |
| 30 Jun 21 | 28,861 | 1,583 | 1,930 | 370 |
| 31 Mar 21 | 25,155 | 1,646 | 1,855 | 355 |
| 31 Dec 20 | 21,641 | 1,521 | 1,801 | 331 |
| 30 Sep 20 | 19,605 | 1,440 | 1,765 | 319 |
| 30 Jun 20 | 19,564 | 1,466 | 1,800 | 325 |
| 31 Mar 20 | 19,007 | 1,457 | 1,905 | 332 |
| 31 Dec 19 | 20,280 | 1,602 | 1,936 | 338 |
| 30 Sep 19 | 17,817 | 1,242 | 1,927 | 350 |
| 30 Jun 19 | 18,607 | 1,168 | 1,781 | 331 |
| 31 Mar 19 | 20,116 | 880 | 1,810 | 307 |
| 31 Dec 18 | 20,264 | 819 | 1,835 | 296 |
| 30 Sep 18 | 24,893 | 636 | 1,863 | 287 |
| 30 Jun 18 | 24,615 | 551 | 1,775 | 355 |
| 31 Mar 18 | 22,023 | 480 | 1,795 | 287 |
| 31 Dec 17 | 19,280 | 469 | 1,742 | 227 |
| 30 Sep 17 | 16,218 | 345 | 1,704 | 143 |
| 30 Jun 17 | 11,605 | 432 | 1,768 | 0 |
| 31 Mar 17 | 9,451 | 709 | 1,614 | 0 |
| 31 Dec 16 | 8,166 | 693 | 1,491 | 0 |
| 30 Sep 16 | 5,145 | 793 | 1,277 | 0 |
| 30 Jun 16 | 4,904 | 879 | 1,178 | 0 |
| 31 Mar 16 | 5,131 | 571 | 1,073 | 0 |
| 31 Dec 15 | 5,340 | 551 | 1,025 | 0 |
| 31 Dec 14 | 5,962 | 245 | 798 | 0 |
Quality Earnings: 002010 has a large one-off gain of CN¥304.7M impacting its last 12 months of financial results to 30th June, 2024.
Growing Profit Margin: 002010's current net profit margins (1.7%) are lower than last year (1.9%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 002010's earnings have declined by 13.7% per year over the past 5 years.
Accelerating Growth: 002010's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 002010 had negative earnings growth (-26.4%) over the past year, making it difficult to compare to the Chemicals industry average (-4.7%).
Return on Equity
High ROE: 002010's Return on Equity (3.4%) is considered low.